USPTO serial 79253079
MEDIGOO
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 11, 2020
- Examiner
- SHANOSKI, JOANNA MARIE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with MEDIGOO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,795*
Plus Government fees of $2,125
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Geza C. Ziegler Jr.
Geza C. Ziegler Jr. ZIEGLER IP LAW GROUP LLC.3135 Easton TurnpikeSHU i-Hub, W-256Fairfield, CT 06825Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Diagnostic preparations for medical or veterinary purposes; Diagnostic materials, namely, medical diagnostic test kits and reagents for testing allergies, pregnancy, fertility, risk of alzheimer, menopause, PSA, heart and blood vessel disease, thyroid function, risk of thrombus and for indicating the presence of helicobacter, urethritis, inflammation, sexually transmitted diseases, borreliosis, diabetes, and drugs, cancer, blood gas levels, vitamin levels, DNA, RNA; Diagnostic testing material for medical use, namely, reagents, test strips, test cassettes, and electronic test analysis devices, sold as a unit, for testing allergies, pregnancy, fertility, risk of alzheimer, menopause, PSA, heart and blood vessel disease, thyroid function, risk of thrombus and for indicating the presence of helicobacter, urethritis, inflammation, sexually transmitted diseases, borreliosis, diabetes, and drugs, cancer, gas levels, vitamin levels, DNA, RNA; Diagnostic reagents for medical use; Diagnostic agents for pharmaceutical use; Diagnostic agents for medical use; Diagnostic preparations for medical purposes; Medical chemical test reagents; Medical diagnostic and analysis test strips for use in testing and analyzing bodily fluids, namely, blood, urine, sweat, saliva and DNA analysis | ACTIVE | — |
| 010 | Medical apparatus and instruments, namely, medical diagnostic apparatus for medical purposes for testing and analyzing DNA and RNA and bodily fluid samples for allergies, pregnancy, fertility, risk of alzheimer, menopause, PSA, heart and blood vessel disease, thyroid function, risk of thrombus and for indicating the presence of helicobacter, urethritis, inflammation, sexually transmitted diseases, borreliosis, diabetes, and drugs, cancer, blood gas levels, vitamin levels; Tools for medical diagnostics, namely, medical diagnostic instruments for the analysis of body fluids; medical diagnostic apparatus for detecting antibodies and antigens for detection of diseases or medical conditions within bodily fluids, namely, diabetes, obesity, heart disease, renal disease, thyroid disorders; Medical diagnostic instruments, namely, self-processing in-vitro diagnostic instruments for the analysis of diseases or medical conditions within bodily fluids; Diagnostic apparatus for pregnancy testing; Diagnostic apparatus for medical purposes, namely, self-processing in-vitro diagnostics apparatus for diagnosing and monitoring of diabetes, heart disease, and other chronic or acute diseases or medical conditions; Diagnostic instruments for medical use, namely, self-processing in-vitro diagnostic instruments for the analysis of bodily fluids for diseases or medical conditions; Medical diagnostic apparatus for medical purposes, namely, self-processing in-vitro diagnostic apparatus for detecting diseases or medical conditions from bodily fluids; Diagnostic testing apparatus for use in immunoassay procedures, namely, medical diagnostic apparatus for detecting diseases or medical conditions from analyzing bodily fluids; Testing instruments for medical diagnostic purposes, namely, medical diagnostic instruments for the analysis of diseases or medical conditions from bodily fluids; Apparatus for carrying-out diagnostic tests for medical purposes, namely, medical diagnostic apparatus for detecting diseases or medical conditions from bodily fluid samples; Urine testing instruments for medical diagnostic purposes; Diagnostic testing instruments for use in immunoassay procedures; membrane test plates for use in medical diagnostics, namely, medical diagnostic test plates for use in screening diseases or medical conditions within bodily fluids in humans; Tools for medical diagnostics, namely, surgical instruments for medical use; Medical apparatus for testing the level of glucose in the blood; Electric instruments for medical use in the diagnosis of blood disorders; Medical test kits for diabetes monitoring for home use; Blood testing apparatus; Testing apparatus for medical purposes, namely, self-processing in-vitro diagnostic testing apparatus, namely, apparatus for blood testing or blood property monitoring; Apparatus for blood tests; Blood glucose testing apparatus; Blood pressure testing apparatus; Medical instruments for drug abuse testing, namely, self-processing in-vitro diagnostic instruments; Medical instruments for infectious disease testing, namely, self-processing in-vitro diagnostic instruments; Blood testing equipment, namely, self-processing in-vitro diagnostic equipment in the nature of blood sampling tubes; Diagnostic measuring apparatus for medical use, namely, medical diagnostic apparatus for analyzing and measuring bodily fluids; Diagnostic, examination, and monitoring equipment, namely, medical equipment and monitors, namely, medical diagnostic apparatus for detecting antibodies and antigens for detection of diseases or medical conditions within bodily fluids, namely, diabetes, obesity, renal disease, thyroid disorders, allergies, pregnancy, fertility, risk of alzheimer, menopause, PSA, heart and blood vessel disease, risk of thrombosis, helicobacter, urethritis, inflammation, sexually transmitted diseases, borreliosis, diabetes, and drugs, cancer, blood gas levels, vitamin levels, DNA | ACTIVE | — |
| 035 | Retail store services featuring medical diagnostic preparations and materials; Retail store services featuring diagnostic reagents for medical use; Retail store services featuring diagnostic agents for pharmaceutical use; Retail store services featuring diagnostic testing materials for medical use; Wholesale store services featuring diagnostic testing materials for medical use; Retail store services featuring diagnostic agents for medical use; Wholesale store services in relation to diagnostic agents for medical use; Online retail store services featuring diagnostic agents for medical use; Retail store services featuring diagnostic preparations for medical purposes; Wholesale store services featuring diagnostic preparations for medical purposes; Online retail store services featuring diagnostic preparations for medical purposes; Retail store services featuring medical chemical test reagents; Wholesale store services featuring medical chemical test reagents; Online retail store services featuring medical chemical test reagents; Retail store services featuring medical diagnostic test strips; Wholesale store services featuring medical diagnostic test strips; Online retail store services featuring medical diagnostic test strips; Retail store services featuring medical apparatus and instruments; Wholesale store services featuring medical apparatus and instruments; Online retail store services featuring medical apparatus and instruments; Retail store services featuring tools for medical diagnostics; Wholesale store services featuring tools for medical diagnostics; Online retail store services featuring tools for medical diagnostics; Retail store services featuring diagnostic apparatus for medical purposes; Wholesale store services featuring diagnostic apparatus for medical purposes; Online retail store services featuring diagnostic apparatus for medical purposes; Retail store services featuring medical diagnostic saliva pads; Wholesale store services featuring medical diagnostic saliva pads; Online retail store services featuring medical diagnostic saliva pads; Retail store services featuring medical diagnostic, examination, and monitoring equipment; Wholesale store services featuring medical diagnostic, examination, and monitoring equipment; Online retail store services in relation to diagnostic, examination, and monitoring equipment; Retail store services featuring diagnostic measuring apparatus for medical use; Wholesale store services featuring diagnostic measuring apparatus for medical use; Online retail store services featuring diagnostic measuring apparatus for medical use; Retail store services featuring medical diagnostic saliva vials; Wholesale store services featuring medical diagnostic saliva vials; Online retail store services featuring medical diagnostic saliva vials | ACTIVE | — |
| 042 | Medical and pharmacological research services; all the aforementioned services excluding any prophylactic and therapeutic services | ACTIVE | — |
| 044 | Medical services; health assessment surveys; consulting services relating to health care in the field of diagnostics and disease prevention; health counselling; health advice and information services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Medigoo Oy
- Other trademarks owned by Medigoo Oy
- Other trademarks owned by Medigoo Oy
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named MEDIGOO
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 11, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Dec 28, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 8, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 8, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 23, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 18, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 18, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 18, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 19, 2020 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 1, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 1, 2020 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 11, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 14, 2020 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Aug 11, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 29, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 29, 2020 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| May 29, 2020 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| May 26, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 26, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 13, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 13, 2020 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| May 6, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 9, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 9, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 9, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 9, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 9, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 30, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 30, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 30, 2020 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Feb 12, 2020 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Jan 31, 2020 | LIME | LIMITATION FROM THE IB - REQUEST EXAM REVIEW | — |
| Jan 31, 2020 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Dec 13, 2019 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Sep 30, 2019 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Sep 30, 2019 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 30, 2019 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 13, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 12, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 12, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 6, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 16, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 16, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 8, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 7, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 6, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 4, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 4, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 28, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |